protein
microarray
increasingli
use
omic
era
research
multipl
format
share
basic
requir
investig
interact
ten
thousand
protein
simultan
import
translat
applic
biomark
discoveri
guid
patient
diagnosi
treatment
prognosi
well
drug
discoveri
vaccin
antigen
identif
protein
microarray
facilit
rapid
systemat
highthroughput
approach
probe
entir
pathogen
proteom
fraction
thereof
immunoreact
approach
form
part
revers
vaccinolog
workflow
aid
discoveri
potenti
diagnost
marker
mycobacterium
tuberculosi
sarscoronaviru
well
potenti
vaccin
candid
human
pathogen
includ
plasmodium
falciparum
p
falciparum
malaria
caus
death
per
year
major
public
health
import
subsaharan
africa
recent
gain
reduc
burden
appear
stall
despit
ongo
control
effort
effort
design
highli
effect
vaccin
would
protect
diseas
hamper
complex
organ
multistag
life
cycl
genom
encod
protein
express
variabl
differ
tissu
infect
develop
host
coupl
impress
array
strategi
gener
protein
polymorph
protein
variant
redund
erythrocyt
invas
pathway
facilit
immun
evas
consequ
although
effort
develop
highli
effect
malaria
vaccin
ongo
centuri
goal
yet
achiev
current
lead
vaccin
candid
p
falciparum
malaria
limit
efficaci
induc
shortliv
protect
immun
multipl
p
falciparum
andor
p
vivax
protein
array
design
past
decad
help
identifi
priorit
potenti
malaria
vaccin
antigen
candid
major
array
manufactur
use
either
e
colibas
wheat
germ
cell
free
invitro
transcriptiontransl
express
system
largest
date
includ
entir
p
falciparum
proteom
protein
select
base
stagespecif
transcript
protein
express
subcellular
local
secondari
protein
structur
document
immunogen
human
anim
model
howev
invitro
transcriptiontransl
system
rel
poor
gener
function
surfac
protein
frequent
requir
disulphid
bond
andor
posttransl
modif
attain
correct
threedimension
structur
nevertheless
subsequ
studi
downselect
protein
initi
panel
indic
essenti
parasit
genom
yet
evalu
context
immun
addit
protein
test
independ
smaller
scale
studi
account
margin
increas
proport
parasit
proteom
evalu
date
studi
ration
select
merozoit
protein
establish
plausibl
target
antibodi
evalu
antibodi
associ
protect
longitudin
studi
use
standard
elisabas
approach
highlight
import
evalu
broad
repertoir
antigen
combin
antibodi
respons
studi
acquir
immun
howev
still
remain
need
common
platform
standard
protein
express
highthroughput
antibodi
detect
method
appli
wide
across
differ
clinic
studi
would
acceler
identif
protect
antibodi
target
facilit
comparison
studi
popul
contribut
vaccin
candid
discoveri
well
valid
priorit
exist
candid
clinic
trial
design
novel
protein
microarray
focus
merozoit
stage
target
immun
prevent
reduc
clinic
symptom
malaria
per
case
infecti
diseas
hypothes
protein
associ
surfac
invas
p
falciparum
merozoit
would
access
target
protect
antibodi
mine
literatur
identifi
multipl
potenti
surfaceassoci
merozoit
protein
ad
new
protein
identifi
immunogen
adult
malariaendem
countri
proteom
andor
bioinformat
featur
suggest
merozoit
surfaceloc
secret
andor
involv
erythrocyt
invas
express
purifi
protein
print
custom
microarray
refer
kilchip
origin
kemriwellcom
trust
research
programm
kilifi
kenya
major
work
carri
demonstr
kilchip
highli
specif
minim
inter
intraassay
variat
strongli
correl
equival
data
acquir
use
goldstandard
monoplex
elisa
aim
design
microarray
would
includ
protein
alreadi
consid
vaccin
candid
well
novel
protein
studi
context
protect
immun
would
serv
multipl
purpos
valid
exist
vaccin
candid
new
sampl
set
ii
identif
novel
potenti
candid
iii
facilit
headtohead
comparison
select
candid
experi
end
select
panel
antigen
previous
publish
zenono
et
al
richard
et
al
crosnier
et
al
tetteh
et
al
raj
et
al
polley
et
al
kimbi
et
al
metzger
et
al
taylor
et
al
burghau
holder
inclus
kilchip
protein
known
predict
anchor
associ
surfac
merozoit
secret
apic
organel
involv
erythrocyt
invas
shown
correl
protect
clinic
malaria
also
includ
novel
protein
select
protein
discoveri
pipelin
employ
proteom
approach
detect
protein
either
immunogen
locat
surfac
merozoit
downselect
criteria
novel
protein
includ
either
presenc
predict
ntermin
signal
peptid
andor
transmembran
domain
ii
upregul
transcript
late
stage
asexu
life
cycl
iii
predict
role
merozoit
invas
iv
novel
regard
potenti
role
protect
immun
plasmid
contain
codonoptim
gene
interest
either
obtain
plasmid
repositori
addgen
http
wwwaddgeneorg
newli
synthes
geneartag
previous
publish
briefli
predict
signal
peptid
transmembran
domain
exclud
serin
threonin
amino
acid
residu
potenti
nlink
glycosyl
site
nxst
substitut
alanin
codonoptim
gene
interest
subclon
deriv
express
vector
also
obtain
addgen
contain
ntermin
signal
peptid
deriv
mous
kappa
light
chain
drive
secret
antigen
rat
domain
tag
follow
hexahistidin
tag
protein
purif
protein
subsequ
express
use
express
system
invitrogen
accord
manufactur
instruct
briefli
cell
cultur
densiti
cellsml
transfect
express
vector
use
expifectamin
transfect
reagent
invitrogen
cell
incub
orbit
shaker
rpm
cultur
supernat
harvest
day
posttransfect
protein
purifi
use
ninta
purif
column
invitrogen
major
protein
includ
kilchip
express
use
mammalian
express
system
minor
protein
express
e
coli
use
vector
produc
fusion
protein
carrier
glutathionestransferas
gst
maltosebind
protein
mbp
respect
transform
e
coli
cell
express
previous
describ
gene
encod
pf
protein
amplifi
p
falciparum
cdna
use
previous
describ
primer
pcr
product
clone
express
vector
transform
plyss
ecoli
cell
cell
expans
induct
protein
express
subsequ
purif
perform
previous
publish
purifi
recombin
protein
dialys
phosphat
buffer
salin
quantifi
use
nanodrop
thermo
scientif
print
onto
nitrocellulos
slide
detail
provid
supplementari
inform
five
fifteen
purifi
recombin
protein
denatur
mm
trishcl
ph
sigma
contain
urea
sigma
protein
reduc
mm
dithiothreitol
sigma
alkyl
mm
iodoacetamid
sigma
precipit
use
cold
aceton
pellet
protein
resuspend
urea
mm
trishcl
ph
digest
trypsinlysc
mix
promega
accord
manufactur
instruct
use
two
step
insolut
digest
peptid
desalt
use
pipett
ziptip
millipor
dri
use
speedvac
concentr
thermo
scientif
resuspend
acetonitril
formic
acid
peptid
load
use
dionex
ultim
nanoflow
ultrahighpressur
liquid
chromatographi
system
thermo
scientif
cm
trap
column
thermo
scientif
chromatograph
separ
peptid
carri
reversephas
cmlong
column
thermo
scientif
maintain
elut
gradient
mobil
phase
b
acetonitril
formic
acid
flow
rate
peptid
measur
use
lc
instrument
consist
dionex
ultim
nanoflow
ultrahighpressur
liquid
chromatographi
system
thermo
scientif
coupl
via
nanoelectrospray
ion
sourc
thermo
scientif
q
exact
orbitrap
mass
spectromet
thermo
scientif
set
resolut
automat
gain
control
agc
target
maximum
inject
time
ms
scan
rang
mz
set
resolut
agc
target
maximum
inject
time
ms
isol
window
mz
top
intens
ion
select
fragment
higherenergi
collis
fragment
use
normal
collis
energi
ion
subsequ
exclud
next
mass
spectrometri
raw
file
search
proteom
discover
softwar
version
thermo
scientif
use
mascot
server
matrix
scienc
use
concaten
databas
human
plasmodium
falciparum
protein
fasta
sequenc
cystein
carbamidomethyl
set
fix
modif
deamid
asparagin
glutamin
methionin
oxid
variabl
modif
fals
discoveri
rate
fdr
set
protein
peptid
maximum
two
miss
cleavag
allow
databas
search
minimum
two
uniqu
peptid
protein
consid
posit
identif
two
protein
select
circular
dichroism
spectroscopi
analysi
briefli
phosphat
buffer
mm
ph
nacl
sampl
phosphat
buffer
degass
vacuum
room
temperatur
cd
spectra
record
spectropolarimet
jasco
six
accumul
taken
per
protein
continu
scan
taken
use
mm
cm
quartz
cuvett
scan
rate
nmmin
band
width
nm
resolut
nm
raw
cd
data
ellipt
mdeg
normal
protein
concentr
number
residu
yield
mean
residu
ellipt
mass
spectrometri
raw
file
gener
analyz
current
studi
deposit
proteomexchang
via
massiv
partner
repositori
follow
titl
kilchip
novel
plasmodium
falciparum
merozoit
protein
microarray
facilit
malaria
vaccin
candid
priorit
ftp
dataset
avail
ftp
design
protein
microarray
test
uniqu
serum
sampl
per
slide
custom
barcod
slide
identif
four
slide
fit
hybrid
cassett
arrayit
corpor
aryc
thu
accommod
sampl
per
cassett
sampl
per
hybrid
workstat
aryc
contain
hybrid
cassett
figur
slide
contain
ident
protein
miniarray
miniarray
featur
print
spot
volum
pl
per
spot
recombin
p
falciparum
protein
n
control
n
print
miniarray
triplic
concentr
use
printer
ultra
marathon
microarray
arrayjet
print
protocol
first
control
spot
human
igg
jackson
immunoresearch
serv
landmark
demarc
four
edg
miniarray
spot
match
edg
miniarray
purifi
human
igg
jackson
immunoresearch
spot
serv
second
control
confirm
activ
secondari
antibodi
util
assay
protein
print
buffer
glycerolpb
spot
use
third
set
control
allow
monitor
background
reactiv
detect
potenti
protein
carryov
print
last
set
control
mbp
gst
protein
spot
control
potenti
antibodi
reactiv
tag
present
one
recombin
p
falciparum
antigen
thu
miniarray
contain
total
featur
deriv
p
falciparum
recombin
protein
protein
includ
twice
control
print
triplic
optim
concentr
individu
protein
serum
sampl
secondari
antibodi
checkerboard
titrat
protein
print
nitrocellulos
slide
oncyt
supernova
gracebio
concentr
use
ultra
marathon
microarray
arrayjet
inkjet
print
technolog
command
center
arrayjet
print
carri
rel
humid
dri
step
slide
incub
overnight
array
print
storag
slide
box
dessic
use
salt
scan
carri
high
photomultipli
pmt
nm
wavelength
green
channel
verifi
postprint
qualiti
nm
wavelength
red
channel
allow
visual
landmark
spot
print
slide
care
assembl
onto
hybrid
cassett
seal
use
silicon
gasket
aryc
form
leakproof
individu
well
modifi
publish
protocol
detect
antibodi
briefli
well
wash
thrice
tween
buffer
salin
nacl
mm
kcl
mm
mm
mm
hepe
hb
follow
hb
remov
unbound
protein
nonspecif
bind
slide
surfac
prevent
block
tween
h
room
temperatur
rotat
microarray
hybrid
station
aryc
rpm
well
subsequ
wash
thrice
incub
overnight
serum
dilut
rotat
rpm
hybrid
station
thereaft
well
wash
describ
incub
donkey
antihuman
fragment
specif
h
room
temperatur
follow
three
wash
slide
care
disassembl
hybrid
cassett
rins
thrice
distil
water
dri
centrifug
g
min
use
combislid
adapt
eppendorf
store
slide
box
dark
slide
scan
use
genepix
b
scanner
coupl
genepix
pro
microarray
acquisit
analysi
softwar
molecular
devic
standard
protocol
indirect
elisa
perform
previous
describ
briefli
predetermin
concentr
recombin
protein
either
heattreat
min
left
untreat
coat
overnight
elisa
plate
dynex
immunolon
well
wash
four
time
pbst
phosphatebuff
tween
block
room
temperatur
skim
milk
marvel
pbst
h
individu
well
wash
incub
either
test
sera
panel
monoclon
antibodi
overnight
wash
four
time
pbst
incub
h
room
temperatur
respect
horseradish
peroxidaseconjug
secondari
antibodi
dilut
marvelpbst
well
wash
four
time
pbst
incub
room
temperatur
substrat
develop
buffer
consist
ophenylenediamin
dihydrochlorid
sigmafast
reaction
stop
per
well
absorb
read
nm
studi
carri
accord
recommend
declar
helsinki
kenyan
nation
scientif
ethic
review
unit
seru
written
inform
consent
subject
protocol
approv
seru
refer
number
sampl
lifelong
adult
resid
junju
kilifi
kenya
collect
use
assay
optim
n
sera
assay
antibodi
respons
wellstudi
recombin
merozoit
protein
use
monoplex
elisa
assay
data
compar
gener
protein
print
kilchip
five
serum
sampl
adult
resid
sweden
report
travel
malariaendem
region
design
malaria
sera
mn
use
neg
control
purifi
malaria
immunoglobulin
mig
obtain
pool
healthi
malawian
adult
use
gener
standard
curv
previous
describ
addit
serum
pool
kenyan
adult
resid
kilifi
kenya
design
malaria
immun
sera
mi
serv
second
posit
control
spot
intens
acquir
use
genepix
scanner
molecular
devic
background
prescan
purificationtag
intens
subtract
analysi
within
sampl
variabl
use
coeffici
variat
cv
standard
deviat
mean
fluoresc
intens
mfi
use
twostep
variancestabil
normal
minim
systemat
variat
commonli
observ
type
data
first
step
handl
differ
could
occur
differ
batch
data
machin
day
use
combat
sva
packag
r
second
step
variancestabil
normal
use
minim
systemat
variat
commonli
observ
type
data
one
hundr
ten
p
falciparum
merozoit
protein
select
literatur
base
surfac
local
known
predict
role
erythrocyt
invas
associ
protect
immun
twentyeight
addit
novel
protein
identifi
use
combin
immunoproteom
bioinformat
p
falciparum
protein
novel
target
success
print
onto
kilchip
figur
supplementari
tabl
includ
fulllength
ectodomain
largest
predict
extracellular
loop
multimembran
protein
protein
fragment
obtain
differ
region
eight
uniqu
protein
thirteen
protein
fragment
correspond
polymorph
variant
n
n
n
n
figur
supplementari
tabl
remain
protein
base
p
falciparum
sequenc
total
uniqu
p
falciparum
merozoit
protein
print
kilchip
two
antigen
print
twice
serv
addit
intern
control
qualiti
major
recombinantli
express
proteinsprotein
fragment
includ
kilchip
valid
elsewher
includ
demonstr
specif
proteinprotein
interact
subset
wellstudi
protein
name
evalu
use
monoclon
antibodi
target
conform
disulfideconstrain
epitop
protein
recombin
protein
test
mab
mab
mab
mab
mab
mab
shown
figur
monoclon
antibodi
highli
reactiv
respect
antigen
show
reactiv
target
antigen
heatdenatur
confirm
presenc
conform
disulfideconstrain
epitop
panel
recombin
protein
expect
low
neglig
reactiv
observ
monoclon
antibodi
offtarget
recombin
protein
presenc
heatlabil
epitop
confirm
test
nativ
heatdenatur
recombin
protein
reactiv
mi
shown
figur
decreas
immunoreact
observ
protein
heatdenatur
howev
minim
drop
immunoreact
observ
suggest
presenc
linear
epitop
collect
result
suggest
protein
includ
kilchip
fold
correctli
contain
heatlabil
conform
epitop
addit
circular
dichroism
analysi
spatr
indic
protein
appear
fold
supplementari
figur
novel
protein
report
express
use
cell
condit
lend
support
qualiti
regard
posttransl
modif
disulfid
bond
format
puriti
novel
protein
assess
use
reduc
sd
gel
massspectrometri
analysi
nineteen
novel
protein
n
includ
kilchip
readili
detect
coomassi
stain
sd
gel
migrat
size
compat
predict
molecular
weight
supplementari
figur
massspectrometri
analysi
confirm
ident
major
recombin
protein
supplementari
tabl
confirm
specif
antibodi
detect
individu
miniarray
probe
follow
posit
neg
control
malaria
immun
sera
mi
ii
malaria
sera
mn
iii
sampl
buffer
consist
tween
expect
strong
fluoresc
detect
miniarray
landmark
blue
commerci
human
igg
green
whilst
none
detect
print
buffer
yellow
figur
panel
probe
mi
high
level
antibodi
reactiv
multipl
p
falciparum
protein
clearli
visibl
figur
panel
contrast
probe
mn
neglig
antibodi
reactiv
observ
similarli
probe
sampl
buffer
nil
minim
reactiv
observ
p
falciparum
protein
figur
panel
respect
explor
specif
compar
antibodi
reactiv
select
previous
character
protein
individu
sampl
kenyan
adult
n
malaria
swede
n
intens
antibodi
reactiv
vari
select
protein
order
pf
ripr
figur
supplementari
figur
median
minimummaximum
fluoresc
intens
mfi
respons
respect
kenyan
adult
mfi
respons
ripr
low
respect
figur
contrast
reactiv
p
falciparum
protein
low
neglig
probe
nonmalaria
expos
serum
swedish
adult
figur
supplementari
figur
wellcharacter
immunodomin
merozoit
antigen
ripr
appear
primari
target
natur
acquir
antibodi
respons
studi
direct
comparison
antibodi
respons
multipl
antigen
evalu
use
kilchip
protein
print
concentr
would
test
simultan
sera
provid
inform
rel
immunogen
panel
merozoit
antigen
supplementari
figur
intraassay
variabl
test
use
serum
sampl
obtain
kenyan
adult
resid
kilifi
antibodi
measur
protein
spot
replic
test
assay
day
strongli
posit
correl
spearman
r
p
figur
interassay
variabl
test
use
posit
neg
control
sera
antibodi
reactiv
measur
repeatedli
five
separ
microarray
slide
print
five
consecut
day
use
ident
print
condit
shown
figur
averag
signal
intens
individu
protein
highli
reproduc
determin
durabl
microarray
slide
measur
respons
batch
slide
month
period
use
refer
reagent
mig
slide
print
day
ident
print
condit
batch
recombin
protein
tripl
dilut
mig
use
measur
respons
protein
gener
standard
curv
perform
pairwis
comparison
slope
sigmoid
curv
gener
antigen
period
n
sigmoid
curv
pairwis
comparison
per
antigen
observ
signific
differ
slope
pairwis
comparison
protein
ttest
p
protein
whose
slope
differ
significantli
eight
protein
singl
curv
differ
protein
significantli
differ
slope
result
protein
print
array
shown
figur
demonstr
curv
major
protein
compar
indic
detect
respons
month
post
print
without
signific
variat
compar
measur
obtain
use
protein
repres
p
falciparum
protein
includ
array
print
kilchip
vs
ident
protein
use
standard
elisa
sampl
kenyan
adult
shown
figur
strong
posit
spearman
correl
coeffici
r
observ
antibodi
measur
kilchip
standard
elisa
p
sixtyseven
percent
protein
test
correl
coeffici
r
figur
wider
dynam
rang
antibodi
measur
evid
protein
array
assay
observ
figur
subset
sampl
whose
mfi
valu
rang
optic
densiti
valu
red
box
upper
limit
detect
elisa
kilchip
new
protein
microarray
design
simultan
quantifi
antibodi
multipl
p
falciparum
merozoit
protein
current
configur
includ
protein
major
fulllength
ectodomain
secret
surfac
expos
protein
facilit
standard
measur
antibodi
multipl
merozoit
protein
cohort
studi
control
human
malaria
infect
current
use
identifi
priorit
potenti
vaccin
candid
util
evalu
antibodi
dynam
monitor
antibodi
decay
longev
chip
flexibl
adapt
includ
fewer
protein
allel
variant
select
protein
fulllength
protein
function
relev
domain
protein
interest
adapt
chip
could
expand
current
speciesspecif
focu
p
falciparum
kilchip
design
test
addit
plasmodium
speci
singli
parallel
particular
import
research
set
subsaharan
africa
chip
durabl
easili
store
transport
share
partner
laboratori
modest
invest
tool
could
transform
pace
p
falciparum
antibodi
respons
data
gener
across
african
contin
principl
could
appli
infect
ultim
contribut
improv
health
develop
diagnost
vaccin
although
protein
microarray
exist
sinc
earli
none
design
develop
africa
specif
studi
natur
acquir
immun
p
falciparum
malaria
merozoit
addit
kilchip
consist
predominantli
merozoit
specif
protein
major
fulllength
ectodomain
consider
improv
evalu
segment
protein
case
preexist
protein
microarray
avail
p
falciparum
enabl
use
recent
publish
method
transient
protein
express
p
falciparum
surfac
protein
mammalian
cell
mani
protein
includ
kilchip
known
immunogen
vari
degre
natur
exposur
malaria
parasit
evalu
hand
cohort
studi
typic
exact
natur
size
qualiti
antigen
test
studi
vari
consider
make
difficult
accur
compar
result
consequ
although
antigen
studi
nearli
year
still
clear
protein
priorit
vaccin
candid
clinic
trial
kilchip
provid
standard
tool
enabl
headtohead
comparison
immunoreact
larg
number
protein
multipl
cohort
one
studi
alreadi
underway
sampl
least
distinct
geograph
locat
spread
across
african
countri
test
use
kilchip
smart
southsouth
malaria
antigen
research
partnership
highlight
potenti
strength
kilchip
demonstr
kilchip
sensit
tool
detect
p
falciparum
specif
antibodi
respons
highli
reproduc
within
assay
strong
concord
goldstandard
monoplex
elisa
observ
compar
result
report
differ
p
falciparum
microarray
current
use
crucial
antibodi
measur
stabl
kilchip
month
postprint
provid
suitabl
time
frame
test
multipl
sampl
probabl
due
addit
glycerol
recombin
protein
time
print
provid
stabil
effect
protein
prevent
degrad
slide
conveni
store
desicc
comparison
standard
elisa
protocol
microarray
util
serum
measur
respons
protein
simultan
compar
requir
elisa
assay
number
protein
similarli
less
recombin
protein
requir
laser
scan
data
acquisit
genepix
b
scanner
allow
much
wider
dynam
rang
antibodi
measur
lastli
custom
microarray
format
could
scale
upward
downward
adapt
meet
specif
requir
current
version
kilchip
singl
slide
miniarray
contain
protein
spot
redesign
includ
less
protein
focu
allel
version
specif
protein
facilit
simultan
character
stage
speciesspecif
antibodi
respons
although
select
proteinsprotein
fragment
inclus
kilchip
unabl
obtain
recombin
protein
target
due
challeng
protein
express
includ
target
glurp
also
report
difficult
obtain
recombin
form
previou
studi
also
dbl
domain
previous
obtain
solubl
recombin
form
use
baculoviru
express
system
yet
establish
within
laboratori
also
observ
low
antibodi
respons
merozoit
protein
ripr
similar
respons
measur
adult
kenya
mali
howev
higher
respons
protein
express
wheat
germ
cellfre
express
system
report
children
papua
new
guinea
suggest
protein
express
system
use
may
influenc
antibodi
respons
measur
anoth
limit
kilchip
major
protein
base
p
falciparum
isol
may
underestim
respons
highli
polymorph
protein
limit
evalu
antigen
divers
humor
respons
immun
effort
underway
gener
addit
protein
array
includ
allel
variant
specif
protein
warrant
studi
lastli
adsorpt
protein
onto
nitrocelluloseco
slide
may
interfer
protein
structur
consequ
detect
conformationdepend
antibodi
respons
howev
solidsurfac
platform
elisa
wide
util
antibodi
detect
vaccin
candid
discoveri
priorit
multipl
infecti
noninfecti
diseas
current
futur
version
kilchip
essenti
multicent
prospect
cohort
studi
design
identifi
correl
protect
allow
research
commun
rapidli
compar
result
headtohead
fast
track
priorit
new
old
potenti
vaccin
candid
would
bridg
import
gap
urgent
need
evid
base
could
guid
develop
next
gener
malaria
vaccin
effort
underway
make
resourc
could
provid
minim
cost
malaria
research
commun
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
